Entrada Therapeutics has secured authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to ...

Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based platform, ...

Investigational treatments—therapies not yet approved for market introduction—provide a beacon of hope for tackling complex ...

Discover the top 3 undervalued Life Sciences Tools & Services stocks for Thursday, January 30 based on AAII’s Stock Grades.

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the ...

Demand slipped for several large contract research organizations last year, and a new report from William Blair analysts ...

Our mission is to support the development of Clinical Psychology, both as a profession and as a body of knowledge and skills. By working collaboratively with a number of organisations including the ...

Clinical research tech firm Advarra has unveiled a new digital solution meant to help speed up study starts and facilitate collaboration between trial sponsors and research sites.

Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 5,720,000 shares, a growth ...